corneal cells
Recently Published Documents


TOTAL DOCUMENTS

185
(FIVE YEARS 25)

H-INDEX

26
(FIVE YEARS 3)

Pharmaceutics ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 2139
Author(s):  
Rita Mencucci ◽  
Giovanni Strazzabosco ◽  
Virginia Cristofori ◽  
Andrea Alogna ◽  
Daria Bortolotti ◽  
...  

This study aimed to evaluate the mucoadhesive and regenerative properties of a novel lubricating multimolecular ophthalmic solution (GlicoPro®) extracted from snail mucus and its potential anti-inflammatory and analgesic role in the management of dry eye disease (DED). GlicoPro bio-adhesive efficacy was assessed using a lectin-based assay, and its regenerative properties were studied in a human corneal epithelial cell line. In vitro DED was induced in human corneal tissues; the histology and mRNA expression of selected genes of inflammatory and corneal damage biomarkers were analyzed in DED tissues treated with GlicoPro. A higher percentage of bio-adhesivity was observed in corneal cells treated with GlicoPro than with sodium hyaluronate-based compounds. In the scratch test GlicoPro improved in vitro corneal wound healing. Histo-morphological analysis revealed restoration of cellular organization of the corneal epithelium, microvilli, and mucin network in DED corneal tissues treated with GlicoPro. A significant reduction in inflammatory and ocular damage biomarkers was observed. High-performance liquid chromatography-mass spectrometry analysis identified an endogenous opioid, opiorphin, in the peptide fraction of GlicoPro. In conclusion, GlicoPro induced regeneration and bio-adhesivity in corneal cells; moreover, considering its anti-inflammatory and analgesic properties, this novel ophthalmic lubricating solution may be an innovative approach for the management of DED.


Molecules ◽  
2021 ◽  
Vol 26 (22) ◽  
pp. 6810
Author(s):  
Elham Nili ◽  
Damien G. Harkin ◽  
Rebecca A. Dawson ◽  
Neil A. Richardson ◽  
Shuko Suzuki ◽  
...  

A recombinant formulation of silk fibroin containing the arginine–glycine–aspartic acid (RGD) cell-binding motif (RGD-fibroin) offers potential advantages for the cultivation of corneal cells. Thus, we investigated the growth of corneal stromal cells and epithelial cells on surfaces created from RGD-fibroin, in comparison to the naturally occurring Bombyx mori silk fibroin. The attachment of cells was compared in the presence or absence of serum over a 90 min period and analyzed by quantification of dsDNA content. Stratification of epithelial cells on freestanding membranes was examined by confocal fluorescence microscopy and optimized through use of low molecular weight poly(ethylene glycol) (PEG; 300 Da) as a porogen, the enzyme horseradish peroxidase (HRP) as a crosslinking agent, and stromal cells grown on the opposing membrane surface. The RGD-fibroin reduced the tendency of stromal cell cultures to form clumps and encouraged the stratification of epithelial cells. PEG used in conjunction with HRP supported the fabrication of more permeable freestanding RGD-fibroin membranes, that provide an effective scaffold for stromal–epithelial co-cultures. Our studies encourage the use of RGD-fibroin for corneal cell culture. Further studies are required to confirm if the benefits of this formulation are due to changes in the expression of integrins, components of the extracellular matrix, or other events at the transcriptional level.


Pathogens ◽  
2021 ◽  
Vol 10 (8) ◽  
pp. 934
Author(s):  
Myriem Otmani Idrissi ◽  
Jean-Pierre Baudoin ◽  
Anne-Line Chateau ◽  
Sarah Aherfi ◽  
Marielle Bedotto-Buffet ◽  
...  

Background: The SARS-CoV-2 pandemic has impacted tissue transplantation procedures since conjunctivas were found to be associated with coronavirus infection. Here, we investigated infection of a cornea graft from a COVID-19-positive donor. Methods: In order to evaluate the presence of SARS-CoV-2 in the cornea graft we first carried out a qRT-PCR and then we investigated the presence of SARS-CoV-2 by fluorescence and electron microscopy. Conclusions: Although the cornea graft was found to be negative by qRT-PCR, we were able to show the presence of SARS-CoV-2 in corneal cells expressing the SARS-CoV-2 receptor, ACE2. Taken together, our findings may have important implications for the use of corneal tissue in graft indications and open the debate on SARS-CoV-2 transmissibility.


Author(s):  
Ying Xin ◽  
Byung Soo Kang ◽  
Yong-Ping Zheng ◽  
Sze Wan Shan ◽  
Chea-su Kee ◽  
...  

2021 ◽  
Vol 98 (2) ◽  
pp. 159-169
Author(s):  
Melania Olivieri ◽  
Martina Cristaldi ◽  
Salvatore Pezzino ◽  
Giorgia Spampinato ◽  
Roberta Corsaro ◽  
...  
Keyword(s):  

2021 ◽  
Vol 202 ◽  
pp. 108362
Author(s):  
VijayKrishna Raghunathan ◽  
Sydney Garrison Edwards ◽  
Brian C. Leonard ◽  
Soohyun Kim ◽  
Alexander T. Evashenk ◽  
...  

Optica ◽  
2020 ◽  
Vol 7 (8) ◽  
pp. 872
Author(s):  
Viacheslav Mazlin ◽  
Kristina Irsch ◽  
Michel Paques ◽  
Jose-Alain Sahel ◽  
Mathias Fink ◽  
...  

Author(s):  
Kiyofumi Hamashima ◽  
Pradeep Gautam ◽  
Katherine Anne Lau ◽  
Chan Woon Khiong ◽  
Timothy A Blenkinsop ◽  
...  

AbstractThere is a pressing urgency to understand the entry route of SARS-CoV-2 viruses into the human body. SARS-CoV-2 viruses enter through ACE2 receptors after the S proteins of the virus are primed by proteases such as TMPRSS2. Most studies focused on the airway epithelial and lung alveolar cells as the route of infection, while the mode of transmission through the ocular route is not well established. Here, we profiled the presence of SARS-CoV-2 receptors and receptor-associated enzymes at single-cell resolution of thirty-three human ocular cell types. We identified unique populations of corneal cells with high ACE2 expression, among which the conjunctival cells co-expressed both ACE2 and TMPRSS2, suggesting that they could serve as the entry points for the virus. Integrative analysis further models the signaling and transcription regulon networks involved in the infection of distinct corneal cells. Our work constitutes a unique resource for the development of new treatments and management of COVID-19.


Sign in / Sign up

Export Citation Format

Share Document